ENSC

SEC filing ENSC Receives Nasdaq Delisting Notice for $2.5M Equity Deficit, Plans Compliance Submission

10d ago

News Ensysce Biosciences Narrows Loss in Q2

14d ago

News Ensysce Biosciences GAAP EPS of -$0.52 beats by $0.21

17d ago

SEC filing ENSC Amends Series B Preferred Stock Certificate, Corrects Scrivener Error, Updates Exhibit 3.1

71d ago

News Tiny Pain-Focused Biotech Ensysce Biosciences Surges Amid Strategic Review

94d ago

Scanner Unusual volume (2.2x average)

123d ago